Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

By Ulahannan Susanna V.   Brahmer Julie R.  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 325-337

Informa Healthcare

Access to resources Recommend Favorite

The role of new agents in the treatment of non-small cell lung cancer

By Broker L.E.   Giaccone G.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2347-2361

Elsevier

Access to resources Recommend Favorite

Antiangiogenic treatments of advanced non-small cell lung cancer

By Manegold Christian  

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 187-196

Springer Publishing Company

Access to resources Recommend Favorite

Clinical observation of Shenmai injection in the treatment for adverse reactions of chemotherapy on advanced non-small cell lung cancer

By Cao Yang  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 81-83

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

By Carrera S.   Buque A.   Azkona E.   Aresti U.   Calvo B.   Sancho A.   Arruti M.   Nuño M.   Rubio I.   Lobera A.   Lopez C.   Vivanco G.  

Clinical and Translational Oncology, Vol. 16, Iss. 4, 2014-04 ,pp. : 339-350

Springer Publishing Company

Access to resources Recommend Favorite